Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Robert Powell

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Pharmacology|May 12, 2020
Precision Dosing Priority Criteria: Drug, Disease, and Patient Population VariablesRachel J Tyson, Christine C Park, J Robert Powell, et al.
Clinical and Translational Science|April 9, 2020
Rivaroxaban Precision Dosing Strategy for Real-World Atrial Fibrillation PatientsRobyn Konicki, Daniel Weiner, J Herbert Patterson, et al.
Journal of Clinical Pharmacology|July 2, 2016
Utility of Model-Based Approaches for Informing Dosing Recommendations in Specific Populations: Report From the Public AAPS WorkshopIslam R Younis, J Robert Powell, Amin Rostami-Hodjegan, et al.
Journal of Clinical Pharmacology|July 9, 2022
Leveraging a Previously Published Population Pharmacokinetic Model to Predict Rivaroxaban Exposure in Real-World PatientsDaniel Weiner, J Robert Powell, J Herbert Patterson, et al.
Journal of Clinical Pharmacology|January 18, 2008
Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004-2006Yaning Wang, A Venkatesh Bhattaram, Pravin R Jadhav, et al.
Clinical and Translational Science|September 7, 2017
Precision Dosing: Public Health Need, Proposed Framework, and Anticipated ImpactDaniel Gonzalez, Gauri G Rao, Stacy C Bailey, et al.
The AAPS Journal|December 16, 2005
Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applicationsVenkatesh A Bhattaram, Brian P Booth, Roshni P Ramchandani, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Pharmacology|May 12, 2020
Precision Dosing Priority Criteria: Drug, Disease, and Patient Population VariablesRachel J Tyson, Christine C Park, J Robert Powell, et al.
Clinical and Translational Science|April 9, 2020
Rivaroxaban Precision Dosing Strategy for Real-World Atrial Fibrillation PatientsRobyn Konicki, Daniel Weiner, J Herbert Patterson, et al.
Journal of Clinical Pharmacology|July 2, 2016
Utility of Model-Based Approaches for Informing Dosing Recommendations in Specific Populations: Report From the Public AAPS WorkshopIslam R Younis, J Robert Powell, Amin Rostami-Hodjegan, et al.
Journal of Clinical Pharmacology|July 9, 2022
Leveraging a Previously Published Population Pharmacokinetic Model to Predict Rivaroxaban Exposure in Real-World PatientsDaniel Weiner, J Robert Powell, J Herbert Patterson, et al.
Journal of Clinical Pharmacology|January 18, 2008
Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004-2006Yaning Wang, A Venkatesh Bhattaram, Pravin R Jadhav, et al.
Clinical and Translational Science|September 7, 2017
Precision Dosing: Public Health Need, Proposed Framework, and Anticipated ImpactDaniel Gonzalez, Gauri G Rao, Stacy C Bailey, et al.
The AAPS Journal|December 16, 2005
Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applicationsVenkatesh A Bhattaram, Brian P Booth, Roshni P Ramchandani, et al.
Pageof 2